loader2
Partner With Us NRI

Bharat Immunological & Biological Corporation Ltd share Price Today

Company details

28.05
29.19
21.00
43.89
6M Return -17.03%
1Y Return 29.48%
Mkt Cap.(Cr) 124.79
Volume 82,838
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 82,838

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Bharat Immunological & Biological Corporation Ltd shares SWOT Analysis

Strengths (1)

  • Company with Zero Promoter Pledge

Weakness (7)

  • Degrowth in Revenue and Profit
  • Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
  • Declining profits every quarter for the past 2 quarters

Opportunity (1)

  • Stock with Low PE (PE < = 10)

Threats (0)

Data not found

Resistance and support

R1 29.4
R2 29.9
R3 30.5
Pivot

28.71

S1 28.2
S2 27.6
S3 27.1
EMA SMA
29.3
29.8
30.0
29.5
29.6
29.8
30.4
29.6
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Purchase 2022-12-27 44.5 497590 BSE
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Sell 2022-12-27 44.49 340168 BSE
TOPGAIN FINANCE PRIVATE LIMITED Bulk Purchase 2022-12-23 44.12 220559 BSE
Name Category Shares
PRESIDENT OF INDIA PROMOTER 59.25%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Bharat Immunological & Biological Corporation Ltd Stocks COMPARISON

Financials( in Cr) Bharat Immunological & Biological Corporation Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 28.90 1,577.30 1,512.05 4,539.30 1,175.15
% Change 1.05 -1.33 -0.08 -2.11 -0.42
Mcap Cr 124.79 378,447.11 122,077.93 120,504.34 118,247.59
Revenue TTM Cr 44.61 48,496.85 15,790.60 7,767.51 19,547.40
Net Profit TTM Cr -17.06 9,648.44 2,513.47 1,823.38 3,854.40
PE TTM 0.00 37.90 28.67 75.30 30.67
1 Year Return 29.48 50.94 48.72 24.71 102.05
ROCE 0.00 17.20 14.76 19.30 23.94
ROE 0.00 16.13 10.66 14.89 20.64
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 87.80 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 22,015.43 44,980.72
LAST 3M 106,765.53 41,611.09
LAST 6M 195,525.59 13,104.33
LAST 12M 310,530.02 79,314.43

Bharat Immunological & Biological Corporation Ltd Information

Stock PE (TTM)
0
Promoter Holding
59.25%
Book Value
-7.5352
ROCE
0%
ROE
0%
Description
  • Bharat Immunological & Biological Corporation Ltd. (BIBCL) is an Indian pharmaceutical company that produces pharmaceutical formulations, such as Oral Polio Vaccine, Hepatitis B vaccine, zinc tablets, and sanitizers. The company was incorporated in 1989 in Uttar Pradesh.

    BIBCL went public in 1994 and listed its shares on Delhi, Mumbai, and Kanpur stock exchanges. The Bombay Stock Exchange has allotted the number 524663 to BIBCL. As of March 31, 2022, the company’s total market capitalisation is at Rs. 121.34 crore. Bharat Biotech share price as of the same date was Rs. 28.10. Bharat Biotech stock price hit a 52-week high of Rs. 94.50 and recorded a 52-week low of Rs. 28. The latest price to book ratio of Bharat Immunological shares was at 0.88 as of March 31, 2022.

    The pharmaceutical company has a number of worthy milestones. In 1996, BIBCL started bulk production of Oral Polio Vaccines. It received its WHO-GMP certification in 1999. The next year, Bharat Immunological & Biological Corporation Ltd. bagged an order from UNICEF and the Ministry of Health and Family Welfare, Government of India for 170 million doses. In 2001, the company bagged another vaccine order of 270 million doses from UNICEF and the Ministry of Health and Family Welfare.

    In 2006, the company made it to the list of top 20 biotech companies in India for its performance. Since 2007, BIBCL has launched a number of other products, including zinc tablets for treating diarrhoea among young children, diarrhoea treatment kits, bivalent oral polio vaccine, and therapeutic food.

    For the quarter ended December 31st 2021, Bharat Immunological & Biological Corporation Ltd. posted total revenues of Rs. 17.43 crores. For the same period in the previous year, the company posted revenues of Rs. 25.20 crores. BIBCL recorded a loss of Rs. 0.33 crores for the quarter ended December 31st 2021. For the same period in the previous year, the company recorded a total loss of Rs. 1.90 crores. Bharat Immunological & Biological Corporation Ltd. posted earnings per share of -Rs.0.08 for the quarter ended December 31st 2021 compared to -Rs. 0.44 for the same period in the previous year.

Registered Address

BIBCOL OPV Plant Village Chola, , Bulandshahr, Uttar Pradesh, 203203

Tel : 91-5732-238210
Email : sklalacs:yahoo.co.in
Website : http://www.bibcol.com
Registrar

Mas Services Limited

AGM Date (Month) : Dec
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524663
NSE Code :
Book Closure Date (Month) : Dec
BSE Group : B
ISIN : INE994B01014

FAQ’s on Bharat Immunological & Biological Corporation Ltd Shares

You can buy Bharat Immunological & Biological Corporation Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Bharat Immunological & Biological Corporation Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 12, 2024 04:01 PM the closing price of Bharat Immunological & Biological Corporation Ltd was Rs.28.90.

The latest PE ratio of Bharat Immunological & Biological Corporation Ltd as of Jul 12, 2024 04:01 PM is 0.00

The latest PB ratio of Bharat Immunological & Biological Corporation Ltd as of Jul 12, 2024 04:01 PM is -0.26

The 52-week high of Bharat Immunological & Biological Corporation Ltd share price is Rs. 43.89 while the 52-week low is Rs. 21.00

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 12, 2024 04:01 PM, the market cap of Bharat Immunological & Biological Corporation Ltd stood at Rs. 124.79 Cr.

Download App

Download Our App

Play Store App Store
market app